In the News – Latisse for Scalp Moves into Phase 2

Snippet from the article:

Allergan Inc. has moved its eyelash treatment into the second clinical stage of testing as a therapy for baldness and expects to see data by the middle of next year, Chief Executive Officer David Pyott said.

The product, Latisse, was approved in 2008 to aid in eyelash growth, and generated $82 million last year for the Irvine, California-based company. Allergan is currently testing Latisse for men and women against placebo. U.S. regulators generally require three stages of trials before approval.

Read the full story — Botox-Maker Allergan Tests Eyelash Lengthener for Baldness

I know the cost for Latisse as it is right now would be pretty steep for use on the scalp, since it is packaged in small quantities for use in eyelash growth. If this proves successful in treating scalp hair loss, I’m sure that will change. We’re still a way off from that, though.